(In the US) Trump Administration to Link Tylenol Use in Pregnancy to Autism Risk

The Trump administration is preparing to announce a controversial stance linking Tylenol use during pregnancy to autism risk, according to reports by The Washington Post. The move has sparked intense debate over public health, scientific evidence, and the politicisation of medical guidance surrounding one of the world’s most widely used pain relievers.

See also: UK Warns Israel Against Retaliation After Recognising Palestinian State

Alongside the announcement, officials are expected to propose further exploration of leucovorin, a drug that has shown early trial promise in improving outcomes for children with autism. Trump himself hinted at the plan, calling it potentially groundbreaking.

However, leading scientists and medical organisations warn that decades of research consistently attribute autism risk to genetic and environmental factors, not Tylenol. They argue the new stance could undermine trust in established medical guidelines and needlessly alarm expectant mothers.

See also: (In the UK) Actress Lynne McGranger Bids Farewell to Home and Away